Literature DB >> 2292077

Designing clinical trials of treatment for osteoporosis: recruitment and follow-up.

B C Tilley, E L Peterson, M Kleerekoper, E Phillips, D A Nelson, M A Shorck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2292077     DOI： 10.1007/bf02555882

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  11 in total

1.  Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.

Authors:  G F Mazzuoli; M Passeri; C Gennari; S Minisola; R Antonelli; C Valtorta; E Palummeri; G F Cervellin; S Gonnelli; G Francini
Journal:  Calcif Tissue Int       Date:  1986-01       Impact factor: 4.333

2.  Calcitriol treatment is not effective in postmenopausal osteoporosis.

Authors:  S M Ott; C H Chesnut
Journal:  Ann Intern Med       Date:  1989-02-15       Impact factor: 25.391

3.  Osteoporosis as a community health problem: lessons learned from studying hypertension.

Authors:  M Kleerekoper; D A Nelson
Journal:  Henry Ford Hosp Med J       Date:  1988

4.  The effect of fluoride and calcium on spinal bone mineral content: a controlled, prospective (3 years) study.

Authors:  T Hansson; B Roos
Journal:  Calcif Tissue Int       Date:  1987-06       Impact factor: 4.333

5.  Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors:  R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

6.  Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

Authors:  B L Riggs; E Seeman; S F Hodgson; D R Taves; W M O'Fallon
Journal:  N Engl J Med       Date:  1982-02-25       Impact factor: 91.245

7.  Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis.

Authors:  N Mamelle; P J Meunier; R Dusan; M Guillaume; J L Martin; A Gaucher; A Prost; G Zeigler; P Netter
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

8.  Bone response to termination of oestrogen treatment.

Authors:  R Lindsay; D M Hart; A MacLean; A C Clark; A Kraszewski; J Garwood
Journal:  Lancet       Date:  1978-06-24       Impact factor: 79.321

9.  Safety of osteoporosis treatment with sodium fluoride, calcium phosphate and vitamin D.

Authors:  C Hasling; H E Nielsen; F Melsen; L Mosekilde
Journal:  Miner Electrolyte Metab       Date:  1987

10.  Relief of osteoporotic backache with fluoride, calcium, and calciferol.

Authors:  O Grove; B Halver
Journal:  Acta Med Scand       Date:  1981
View more
  1 in total

1.  A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis.

Authors:  M Kleerekoper; E L Peterson; D A Nelson; E Phillips; M A Schork; B C Tilley; A M Parfitt
Journal:  Osteoporos Int       Date:  1991-06       Impact factor: 4.507
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.